PLIC-2 activators refer to a category of chemical agents that target the protein ubiquilin 2, also known as PLIC-2, which is part of the ubiquitin-proteasome system. PLIC-2 is involved in various cellular processes, including protein degradation, cell cycle regulation, and stress response. It functions by interacting with ubiquitinated proteins, guiding them to the proteasome for degradation, and is therefore crucial in maintaining cellular protein homeostasis.
Activators of PLIC-2 can operate through direct or indirect mechanisms to enhance the protein's function. Direct PLIC-2 activators might bind to PLIC-2, influencing its conformation in a way that increases its affinity for ubiquitinated substrates or its ability to interact with the proteasome. This could lead to more efficient clearance of damaged or misfolded proteins from the cell, thus aiding in the regulation of protein quality control. Indirect activators may modulate the expression of PLIC-2, leading to an increase in the levels of the protein in the cell. They could also affect the post-translational modification of PLIC-2, altering its activity or stability. For example, a chemical that inhibits the degradation of PLIC-2 would result in higher intracellular levels of the protein, potentially enhancing its functional activity.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that can cause an accumulation of ubiquitinated proteins, potentially affecting UBQLN2 function. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor that may indirectly increase UBQLN2 activity by increasing cellular ubiquitination. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
ER stress inducer which can activate the unfolded protein response, possibly influencing UBQLN2. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Another ER stress inducer, which can affect UBQLN2's role in protein degradation. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $165.00 $575.00 | 60 | |
Proteasome inhibitor that can indirectly modulate UBQLN2 by impacting ubiquitin-proteasome system. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $134.00 $215.00 $440.00 $496.00 | 19 | |
A selective proteasome inhibitor which can influence ubiquitin-mediated protein degradation. | ||||||
Ixazomib | 1072833-77-2 | sc-489103 sc-489103A | 10 mg 50 mg | $311.00 $719.00 | ||
Proteasome inhibitor, which can indirectly affect the processes UBQLN2 is involved in. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
Hsp90 inhibitor which can affect protein folding and degradation pathways, potentially impacting UBQLN2. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $155.00 | 6 | |
Inhibits proteasomal degradation and induces heat shock response, which may influence UBQLN2. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $127.00 $572.00 $4090.00 $20104.00 | 20 | |
Inhibits proteasomal activity and can potentially affect cellular processes that UBQLN2 is involved in. | ||||||